Effect of Citrus medica leaves in sleep disorder
Phase 2
Completed
- Conditions
- Health Condition 1: null- Insomnia (Anidra)
- Registration Number
- CTRI/2013/10/004097
- Lead Sponsor
- IPGT and RA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Primary insomnia like Insomnia without Identifiable Cause and Psycho-physiologic Insomnia
Exclusion Criteria
Secondary insomnia like Transient Situational Insomnia, Insomnia Associated with Neurologic Disorders, Insomnia Associated with Mental Disorders, Drug or Alcohol-Dependent Insomnia and Insomnia Associated with Other Medical Disorders.
Patient with systemic uncontrolled disease â?? like diabetes, hypertension etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 sleep efficacyTimepoint: at 14th, 28th, 42nd days
- Secondary Outcome Measures
Name Time Method 1 improve sleep quality and quantity <br/ ><br>2 general healthTimepoint: at 14th, 28th days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Citrus medica leaves in treating insomnia?
How does the pharmacological activity of Citrus medica leaves compare to standard insomnia treatments like benzodiazepines and non-benzodiazepine hypnotics?
Are there specific biomarkers that can predict patient response to Citrus medica leaf extracts for insomnia management?
What are the potential adverse events associated with Citrus medica leaf administration and how can they be managed?
What is the therapeutic potential of combining Citrus medica leaves with other natural compounds for insomnia treatment?